Molecular Therapy: Nucleic Acids (Mar 2022)

SARS-CoV-2 causes a significant stress response mediated by small RNAs in the blood of COVID-19 patients

  • Xi Liu,
  • Yan-Zi Wen,
  • Zi-Liang Huang,
  • Xia Shen,
  • Jun-Hao Wang,
  • Yi-Hai Luo,
  • Wen-Xin Chen,
  • Zhao-Rong Lun,
  • Hui-Bin Li,
  • Liang-Hu Qu,
  • Hong Shan,
  • Ling-Ling Zheng

Journal volume & issue
Vol. 27
pp. 751 – 762

Abstract

Read online

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has had a serious impact on the world. In this study, small RNAs from the blood of COVID-19 patients with moderate or severe symptoms were extracted for high-throughput sequencing and analysis. Interestingly, the levels of a special group of tRNA-derived small RNAs (tsRNAs) were found to be dramatically upregulated after SARS-CoV-2 infection, particularly in coronavirus disease 2019 (COVID-19) patients with severe symptoms. In particular, the 3′CCA tsRNAs from tRNA-Gly were highly consistent with the inflammation indicator C-reactive protein (CRP). In addition, we found that the majority of significantly changed microRNAs (miRNAs) were associated with endoplasmic reticulum (ER)/unfolded protein response (UPR) sensors, which may lead to the induction of proinflammatory cytokine and immune responses. This study found that SARS-CoV-2 infection caused significant changes in the levels of stress-associated small RNAs in patient blood and their potential functions. Our research revealed that the cells of COVID-19 patients undergo tremendous stress and respond, which can be reflected or regulated by small non-coding RNA (sncRNAs), thus providing potential thought for therapeutic intervention in COVID-19 by modulating small RNA levels or activities.

Keywords